newsfilter
← Latest News
GlobeNewswire·

Surface Oncology to Present Clinical Update on SRF388 at American Society of Clinical Oncology Annual Meeting

CAMBRIDGE, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that it will share a clini